CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
The project focuses on developing a restorative vascular graft, known as XABG, to treat coronary artery disease without the need for vein harvesting. This innovative implant promotes natural tissue restoration, aiming to improve patient outcomes and reduce complications associated with traditional bypass surgery.
Coronary Artery Disease is caused by narrowing of heart arteries that supply blood, often due to atherosclerosis.
Coronary artery bypass grafting (CABG) is the gold standard surgery to treat it, and it commonly involves harvesting patient’s veins from the legs as grafts.
This collection affects patients causing chronic pain and costly complications.
It also has a high failure rate with >20% implants occluded after 1 year.Xeltis has developed a unique restorative vascular graft (XABG) that elimin…
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Switzerland, ZURICH
Type: SME
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
SME: Yes
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
